Methodological needs in the quality and safety characterisation of nanotechnology-based health products: Priorities for method development and standardisation

Autor: Halamoda-Kenzaoui, B., Vandebriel, R.J., Howarth, A., Siccardi, M., David, C.A.W., Liptrott, N.J., Santin, M., Borgos, S.E., Bremer-Hoffmann, S., Caputo, F.

Publikováno v: In Journal of Controlled Release 10 August 2021 336:192-206

Evaluation of uptake and transport of cationic and anionic ultrasmall iron oxide nanoparticles by human colon cells

Autor: Juillerat-Jeanneret L, Vilà MR, Cengelli F, Miquel JM, Halamoda Kenzaoui B

Publikováno v: International Journal of Nanomedicine, Vol 2012, Iss default, Pp 1275-1286 (2012)

Blanka Halamoda Kenzaoui1, Maya R Vilà2, Josep M Miquel2, Feride Cengelli1, Lucienne Juillerat-Jeanneret11Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland; 2Leitat Technological Center, Barcelo

Externí odkaz: https://doaj.org/article/6c3bfc2ea1bd4cb3969c601b6cc97689

Future perspectives for advancing regulatory science of nanotechnology-enabled health products.

Autor: Halamoda-Kenzaoui B; European Commission Joint Research Centre (JRC), Ispra, Italy., Geertsma R; Centre for Health Protection, National Institute for Public Health & the Environment (RIVM), Bilthoven, The Netherlands., Pouw J; Centre for Health Protection, National Institute for Public Health & the Environment (RIVM), Bilthoven, The Netherlands., Prina-Mello A; Laboratory for Biological Characterization of Advanced Materials (LBCAM), Trinity Translational Medicine Institute (TTMI), Trinity College Dublin, St James's Hospital, Dublin 8, Ireland.; Nanomedicine and Molecular Imaging Group, Clinical Medicine, Trinity Translational Medicine Institute (TTMI), Trinity College Dublin, St James's Hospital, Dublin 8, Ireland.; Trinity St James's Cancer Institute, Trinity College Dublin, St James's Hospital, Dublin 8, Ireland., Carrer M; Laboratory for Biological Characterization of Advanced Materials (LBCAM), Trinity Translational Medicine Institute (TTMI), Trinity College Dublin, St James's Hospital, Dublin 8, Ireland., Roesslein M; Swiss Federal Laboratories for Material Science and Technology, EMPA, St. Gallen, Switzerland., Sips A; Centre for Safety of Substances and Products, National Institute for Public Health & the Environment (RIVM), Bilthoven, The Netherlands., Weltring KM; Gesellschaft Für Bioanalytik Muenster E.V, Muenster, Germany., Spring K; Gesellschaft Für Bioanalytik Muenster E.V, Muenster, Germany., Bremer-Hoffmann S; European Commission Joint Research Centre (JRC), Ispra, Italy. susanne.bremer-hoffmann@ec.europa.eu.

Publikováno v: Drug delivery and translational research [Drug Deliv Transl Res] 2022 Sep; Vol. 12 (9), pp. 2145-2156. Date of Electronic Publication: 2022 Jun 12.

Emerging technologies and their impact on regulatory science.

Autor: Anklam E; Joint Research Centre, EU., Bahl MI; National Food Institute, Technical University, Denmark., Ball R; U.S. Food and Drug Administration., Beger RD; U.S. Food and Drug Administration., Cohen J; U.S. Food and Drug Administration., Fitzpatrick S; U.S. Food and Drug Administration., Girard P; Swissmedic, Switzerland., Halamoda-Kenzaoui B; Joint Research Centre, EU., Hinton D; U.S. Food and Drug Administration., Hirose A; National Institute of Health Sciences, Japan., Hoeveler A; Joint Research Centre, EU., Honma M; National Institute of Health Sciences, Japan., Hugas M; European Food Safety Authority, EU., Ishida S; National Institute of Health Sciences, Japan., Kass GE; European Food Safety Authority, EU., Kojima H; National Institute of Health Sciences, Japan., Krefting I; U.S. Food and Drug Administration., Liachenko S; U.S. Food and Drug Administration., Liu Y; Median Technologies, France., Masters S; U.S. Food and Drug Administration., Marx U; TissUse, Germany., McCarthy T; Pfizer, USA., Mercer T; Garvan Institute, Australia., Patri A; U.S. Food and Drug Administration., Pelaez C; Spanish Council for Scientific Research, Spain., Pirmohamed M; University of Liverpool, UK., Platz S; AstraZeneca, UK., Ribeiro AJ; U.S. Food and Drug Administration., Rodricks JV; Ramboll, USA., Rusyn I; Texas A&M University, USA., Salek RM; International Agency for Research on Cancer, France., Schoonjans R; European Food Safety Authority, EU., Silva P; Canadian Food Inspection Agency, Canada., Svendsen CN; Cedars-Sinai Medical Center, USA., Sumner S; University of North Carolina, Chapel Hill, USA., Sung K; U.S. Food and Drug Administration., Tagle D; National Institutes of Health, USA., Tong L; Universities of Georgia Tech and Emory, USA., Tong W; U.S. Food and Drug Administration., Eijnden-van-Raaij JVD; Dutch Organ-on-Chip Consortium, The Netherlands., Vary N; Canadian Food Inspection Agency, Canada., Wang T; National Medical Products Administration, China., Waterton J; University of Manchester and Bioxydyn Ltd, UK., Wang M; Universities of Georgia Tech and Emory, USA., Wen H; National Institutes for Food and Drug Control, China., Wishart D; University of Alberta, Canada., Yuan Y; The Institute of Cancer Research, UK., Slikker W Jr; U.S. Food and Drug Administration.

Publikováno v: Experimental biology and medicine (Maywood, N.J.) [Exp Biol Med (Maywood)] 2022 Jan; Vol. 247 (1), pp. 1-75. Date of Electronic Publication: 2021 Nov 16.

Bioactive Hybrids Containing Artificial Cell Membranes and Phyto-Gold–Silver Chloride Bio-Nanoparticles.

Autor: Barbinta-Patrascu, Marcela-Elisabeta¹ (AUTHOR) marcela.barbinta@unibuc.ro, Nichita, Cornelia^2,3 (AUTHOR) cornelia.nichita@unibuc.ro, Enculescu, Monica⁴ (AUTHOR) mdatcu@infim.ro, Maraloiu, Valentin-Adrian⁴ (AUTHOR) maraloiu@infim.ro, Bacalum, Mihaela⁵ (AUTHOR) bmihaela@nipne.ro, Ungureanu, Camelia⁶ (AUTHOR) ungureanucamelia@gmail.com, Negrila, Catalin Constantin⁴ (AUTHOR) catalin.negrila@infim.ro, Zgura, Irina⁴ (AUTHOR) cornelia.nichita@unibuc.ro

Publikováno v: International Journal of Molecular Sciences. Nov2024, Vol. 25 Issue 22, p11929. 25p.